KALA BIO, Inc. (NASDAQ:KALA) (“KALA” or the “Company”), today announced that it has entered into definitive agreements for ...

KALA BIO shares jumped over 22% after Oxford Finance acquired a 16.5% stake, amid recent leadership changes and continued ...

The latest update is out from KALA BIO ( (KALA) ).

KALA BIO ( (KALA) ) just unveiled an announcement.

ARLINGTON, Mass, July 11, 2022 (GLOBE NEWSWIRE) -- Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of ...

Kala Bio shares surged after the biopharmaceutical company said it had named David Lazar as chief executive and board chair, following the investor's purchase of $6 million in stock. Kala shares were ...

Blueberries are rich in antioxidants, helping prevent cell damage. They provide a good source of fiber, promoting digestion and gut health. Low in calories, blueberries can aid in weight loss and ...

Shares of Kala Pharmaceuticals surged Wednesday after the small biotechnology company announced a drug candidate for a rare eye disease. The Food and Drug Administration has accepted Kala's ...

KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative therapies for rare and severe diseases of the eye, ...

Alcon has expanded its portfolio of eye disease products by paying $60 million upfront for the rights to two commercial products based on mucus-penetrating particle drug delivery technology. The sale ...

KALA BIO, Inc. (NASDAQ:KALA) (“KALA” or the “Company”), today announced the closing of its previously announced registered ...